DANIEL M. JUNIUS - 16 Feb 2023 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Daniel M. Junius
Issuer symbol
IDXX
Transactions as of
16 Feb 2023
Net transactions value
-$667,166
Form type
4
Filing time
17 Feb 2023, 16:06:03 UTC
Previous filing
01 Feb 2023
Next filing
02 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $451,878 +2,187 +73% $206.62 5,169 16 Feb 2023 Direct
transaction IDXX Common Stock Sale $1,119,044 -2,187 -42% $511.68 2,982 16 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -2,187 -100% 0 16 Feb 2023 Common Stock 2,187 $206.62 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average price of the shares sold ranging from a low of $511.65 to a high of $512.29 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F2 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on May 8, 2019, the date of the 2019 annual meeting of shareholders.
F3 Not applicable.